NM_152490.5:c.1487G>A
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_152490.5(B3GALNT2):c.1487G>A(p.Arg496Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000458 in 1,614,102 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R496G) has been classified as Uncertain significance.
Frequency
Consequence
NM_152490.5 missense
Scores
Clinical Significance
Conservation
Publications
- hypoparathyroidism-retardation-dysmorphism syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet
- early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndromeInheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- encephalopathy, progressive, with amyotrophy and optic atrophyInheritance: AR Classification: STRONG, LIMITED Submitted by: Ambry Genetics, G2P
- autosomal recessive Kenny-Caffey syndromeInheritance: AR Classification: MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -8 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
B3GALNT2 | ENST00000366600.8 | c.1487G>A | p.Arg496Gln | missense_variant | Exon 12 of 12 | 1 | NM_152490.5 | ENSP00000355559.3 | ||
TBCE | ENST00000642610.2 | c.*1460C>T | 3_prime_UTR_variant | Exon 17 of 17 | NM_003193.5 | ENSP00000494796.1 |
Frequencies
GnomAD3 genomes AF: 0.0000789 AC: 12AN: 152122Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000119 AC: 3AN: 251404 AF XY: 0.0000147 show subpopulations
GnomAD4 exome AF: 0.0000410 AC: 60AN: 1461862Hom.: 3 Cov.: 30 AF XY: 0.0000399 AC XY: 29AN XY: 727236 show subpopulations
GnomAD4 genome AF: 0.0000920 AC: 14AN: 152240Hom.: 0 Cov.: 32 AF XY: 0.000134 AC XY: 10AN XY: 74436 show subpopulations
ClinVar
Submissions by phenotype
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 11 Uncertain:1
This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 496 of the B3GALNT2 protein (p.Arg496Gln). This variant is present in population databases (rs111541487, gnomAD 0.008%). This variant has not been reported in the literature in individuals affected with B3GALNT2-related conditions. ClinVar contains an entry for this variant (Variation ID: 473881). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt B3GALNT2 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at